Shu-Jyuan Chang

10PUBLICATIONS
10CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersMedical mycologyMedical parasitologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 26, 2026
Blue light exposure exacerbates Western diet-induced hepatic lipid accumulation and injury via suppression of the SIRT1-NR1D1 axis.

|Apr 08, 2026
Prognostic Value of Ki-67 and Progesterone Receptor for Risk Stratification and Outcomes by Adjuvant Chemotherapy in Early Luminal-Type Breast Cancer.

Hung-Hsun Chen, Shu-Jyuan Chang, Jung-Yu Kan

|Oct 31, 2025
Optimisation of a Standardised Automated Bleaching and Staining Protocol for Melanin-Rich Cytology Specimens.

Chia-Hsing Liu, Shu-Jyuan Chang, Shu-Han Chang

|Aug 01, 2023
An Optimized Melanin Depigmentation Method for Histopathological and Immunohistochemical Staining of Formalin-Fixed Paraffin-Embedded Tissues.

Chia-Hsing Liu, Shu-Jyuan Chang, Sheau-Fang Yang

|Dec 24, 2021
FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer.

Jun-Ping Shiau, Cheng-Che Wu, Shu-Jyuan Chang

|Nov 13, 2021
Correction: Pan et al. Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer. Cancers 2020, 12, 94.

Mei-Ren Pan, Cheng-Che Wu, Jung-Yu Kan

Pageof 2

Frequent Collaborators

4 joint publications

Mei-Ren Pan

2 joint publications

Ming-Feng Hou

2 joint publications

Chi-Wen Luo

1 joint publications

Hui-Ching Wang